A new batch of neflamapimod capsules led to increased plasma drug concentrations and demonstrated improvement (p<0.001 vs. old capsules; ...

Lewy body dementia (LBD) is a type of dementia caused by abnormal protein deposits in the brain, called Lewy bodies. The deposits cause chemical changes in the brain, leading to problems with ...

Roger Shafer celebrated his 45th wedding anniversary with this wife, Linda, who is living with Lewy-body dementia.

Lewy body dementia contains both Parkinson’s disease dementia (PDD) and Dementia with Lewy bodies (DLB). DLB is the second most common cause of dementia in the general population and affects an ...

About Virtual Investor Conferences® Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to ...

Hospice use varies depending on whether a person has Parkinson’s disease, Lewy body dementia or Alzheimer’s disease and those with Parkinson’s may have more unmet needs, a new study finds.

Cognition Therapeutics, Inc. announced promising results from the SHIMMER study of zervimesine (CT1812) in patients with mild-to-moderate dementia with Lewy bodies (DLB), to be presented by Dr ...

This Centre’s research aims to address the cause, cure, care, and prevention of Lewy body dementia. By considering all elements of the disease, this Centre will pave the way for new treatments that ...

Zervimesine is an investigational oral, once-daily pill being developed for the treatment of CNS diseases, including ...

Lewy body dementia (LBD) is a form of dementia that affects a person’s cognitive abilities and movement. The condition is progressive, which means the symptoms worsen over time. LBD occurs due ...